Family with sequence similarity 182 pseudogene

A *pseudogene* is a segment of DNA that closely resembles a functional gene but is non-functional due to disruptive mutations, such as premature stop codons or frameshifts, and thus cannot produce a functional protein product[1][2][3]. Pseudogenes are considered genomic relics, typically incapable of coding for proteins, though some may be transcribed into RNA at low levels. Occasionally, pseudogenes can exert RNA-level regulatory roles (such as acting as competing endogenous RNAs), but the vast majority lack established biological or disease-related functions[3][4]. ### Additional Clarifying Information - **Therapeutic Target Status:** Pseudogenes are, by definition, *not* considered therapeutic targets, as they are non-coding and non-functional in terms of protein product[1][2]. While some pseudogenes have been implicated in regulatory roles, these cases represent exceptions and require further characterization; ENSG00000264617 does not have any such established role. - **Molecular Classification:** "Pseudogene" does not fit within standard molecular classes such as receptor, ion channel, enzyme, transporter, or transcription factor; instead, pseudogenes are classified as non-functional gene relics[1][2]. - **Disease and Biomarker Roles:** Although a few pseudogenes have been reported to exhibit differential expression in cancer or other diseases, for the vast majority—including ENSG00000264617—no direct disease association or biomarker utility is known[3][4]. - **Interacting Drugs & Mechanisms:** No drugs are known to interact with this pseudogene, nor are there any mechanisms of action, as it does not produce a functional molecule that could be the target of therapeutics[1][2]. - **Potential Issues:** The inclusion of a pseudogene (especially unnamed or only described as "family with sequence similarity 182 pseudogene") as a target is typically incorrect in therapeutic research contexts, as pseudogenes are non-functional and cannot serve as classical drug targets[2]. ### Notes - Some pseudogenes are annotated similarly due to high sequence similarity with functional genes, and their presence can occasionally complicate experimental designs, such as PCR or RNAi, leading to off-target effects[1]. - There are rare cases where pseudogenes may acquire regulatory significance, but these require individual experimental validation and are not the norm for "family with sequence similarity 182 pseudogene" or ENSG00000264617. This entry should **not** be included in therapeutic target lists, as it is not a bona fide molecular target.